Abstract

BackgroundEssential thrombocythemia (ET) is a myeloproliferative disorder characterized as excessive platelet production. Early and accurate diagnosis is critical to manage the disease and prevent progression to serious myeloid neoplasms like myelofibrosis or acute myeloid leukemia, though definitive diagnosis remains challenging.Materials and methodsWe retrieved seven publicly available microarray datasets from GEO database. Data preprocessing included normalization and batch correction using limma and SVA packages. Differentially expressed genes (DEGs) were identified via robust rank aggregation (RRA). Protein-protein interaction networks, GO and KEGG analyses were performed. qRT-PCR was used to verify the expression of key genes in control subjects and patients with ET. Immune infiltration was analyzed with CIBERSORT, while logistic regression and LASSO models validated the diagnostic potential of the identified genes. Functional assays including shRNA knockdown, CCK-8, apoptosis detection, and Western blot were conducted in primary CD34+ cell-derived megakaryocytes from ET patients.ResultsEleven key DEGs were identified, and the logistic regression model achieved area under the curve of 0.846 and 0.863 for the training and test sets, respectively. Immune infiltration analysis revealed significant changes in B, T, and NK cells. The qRT-PCR analysis revealed BP1, MMP8, and CEACAM8 up-regulated in ET patients. In particular, LCN2 and MMP8 were functionally validated: knockdown of either gene significantly reduced cell viability and promoted apoptosis in megakaryocytes. Further analysis showed that MMP8 knockdown was associated with reduced IL-17 signaling, while LCN2 knockdown led to inhibition of the NOD-like receptor pathway.ConclusionThis study identified an eleven-gene signature that links IL-17 and NOD-like receptor signaling to megakaryocyte dysfunction and immune dysregulation in ET. In vitro functional experiments suggested that LCN2 and MMP8 may contribut